Owkin lands $11 mln Series A
Owkin, a predictive analytics company that utilizes transfer learning to accelerate drug discovery and development, has secured $11 million in Series A funding. Otium Venture led the round with participation from Cathay Innovation, Plug and Play and NJF Capital. In conjunction with the funding, Bruno Raillard, a partner at Otium Venture, will join Owkin’s board of directors.
16 January 2018•1 min read
